drugset / Trial / NCT00265993
Enoxaparin in Acute Venous Thromboembolic Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Study objectives : * To evaluate the efficacy/safety profile of enoxaparin once a day treatment in acute venous thromboembolic disease.
Timeline
- Start
- 2004-12
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 1.5 mg/kg | Subcutaneous |